Open unicenter phase I trial of a combination therapy of temsirolimus and irinotecan in patients with glioblastoma or brain metastases of solid tumors.
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2017
At a glance
- Drugs Irinotecan (Primary) ; Temsirolimus (Primary)
- Indications Brain metastases; Glioblastoma; Solid tumours
- Focus Adverse reactions
- 22 Nov 2016 Status changed from recruiting to completed.
- 19 Jan 2012 Actual initiation date (Apr 2011) added as reported by German Clinical Trials Register.
- 19 Jan 2012 Status changed from not yet recruiting to recruiting as reported by German Clinical Trials Register.